JAZZ PHARMACEUTICALS INC (JAZZ) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 1067 transactions totaling $175.2M, demonstrating a bearish sentiment with -$145.8M in net insider flow. The most recent transaction on Jan 16, 2026 involved a transaction of 1,599 shares valued at $273.7K.
No significant insider buying has been recorded for JAZZ in the recent period.
No significant insider selling has been recorded for JAZZ in the recent period.
Based on recent SEC filings, insider sentiment for JAZZ is bearish with an Insider Alignment Score of 8/100 and a net flow of -$145.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at JAZZ PHARMACEUTICALS INC (JAZZ) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading JAZZ stock, having executed 1067 transactions in the past 90 days. The most active insider is Bruce C. Cozadd (Executive), who has made 176 transactions totaling $113.6M.
Get notified when executives and directors at JAZZ file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | Pearce Samantha | EVP, Chief Commercial Officer | Payment | 1,599 | $171.16 | $273.7K | |
| Jan 16, 2026 | Pearce Samantha | EVP, Chief Commercial Officer | Award | 3,637 | $N/A | $0 | |
| Jan 16, 2026 | M. Patil Neena | EVP & Chief Legal Officer | Disposition | 3,275 | $171.16 | $560.5K | Large |
| Jan 16, 2026 | M. Patil Neena | EVP & Chief Legal Officer | Award | 8,852 | $N/A | $0 | |
| Jan 16, 2026 | Carr Patricia | SVP, Chief Accounting Officer | Award | 2,370 | $N/A | $0 | |
| Jan 16, 2026 | Elizabeth Henderson Mary | SVP, Technical Operations | Award | 10,116 | $N/A | $0 | |
| Jan 16, 2026 | C. Cozadd Bruce | Executive | Payment | 17,453 | $171.16 | $3.0M | Large |
| Jan 16, 2026 | C. Cozadd Bruce | Executive | Award | 35,917 | $N/A | $0 | |
| Jan 16, 2026 | D. Gala Renee | President & CEO | Payment | 5,371 | $171.16 | $919.3K | C-SuiteLarge |
| Jan 16, 2026 | D. Gala Renee | President & CEO | Award | 12,741 | $N/A | $0 | C-Suite |
| Jan 16, 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Payment | 4,140 | $171.16 | $708.6K | Large |
| Jan 16, 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Award | 11,699 | $N/A | $0 | |
| Dec 9, 2025 | Elizabeth Henderson Mary | Executive | Sale | 2,238 | $169.51 | $379.4K | |
| Dec 5, 2025 | Carr Patricia | Executive | Option Exercise | 4,500 | $140.67 | $633.0K | Large |
| Dec 5, 2025 | Carr Patricia | Executive | Sale | 4,500 | $171.20 | $770.4K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 568 | $160.5M | 59.0% |
Payment(F) | 172 | $61.8M | 22.7% |
Exercise(M) | 71 | $32.9M | 12.1% |
Purchase(P) | 17 | $14.7M | 5.4% |
Disposition(D) | 7 | $1.8M | 0.7% |
Award(A) | 226 | $275.5K | 0.1% |
Other(J) | 3 | $6.4K | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Insider selling pressure at JAZZ PHARMACEUTICALS INC has increased, with 35 insiders executing 1067 transactions across all time. Total sales of $160.5M significantly outpace purchases of $14.7M, resulting in a net outflow of $145.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.